Evidence map›Paper›PMID 42439565›Full record

ArticleMicrobiology spectrum2026

Non-destructive label-free automated identification of bacterial colonies at the species level directly on agar media using digital holography and convolutional neural network algorithms.

Prisca Perlemoine, Jordan Belissard, Bruno Burtschell, Nassim Halli, Luc Martin, Camille Brunet, Maxime Gougis, Patrick Schiavone, Yvan Caspar

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Prisca PerlemoineBAIO-DX, Grenoble, France.ORCID 0000-0001-7490-3622
Jordan BelissardBAIO-DX, Grenoble, France.
Bruno BurtschellBAIO-DX, Grenoble, France.
Nassim HalliBAIO-DX, Grenoble, France.
Luc MartinBAIO-DX, Grenoble, France.
Camille BrunetLaboratoire de bactériologie hygiène hospitalière, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
Maxime GougisBAIO-DX, Grenoble, France.ORCID 0000-0003-1624-7203
Patrick SchiavoneBAIO-DX, Grenoble, France.
Yvan CasparUniv. Grenoble Alpes, CNRS, CHU Grenoble Alpes, CEA, IBS, Grenoble, France.ORCID 0000-0002-8332-9383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to establish a thorough proof of concept for an innovative, fully automated, non-destructive, and label-free approach for the identification of bacterial colonies directly on agar plates, integrating digital holography with artificial intelligence, and to evaluate its performance. High-resolution holographic images of individual bacterial colonies grown on translucent brain-heart agar plates were captured every 30 min over an 18-h incubation period (530 MPx per full plate). Imaging was performed using a large field 1× magnification system, a partially coherent LED light source, and a high-resolution complementary metal-oxide-semiconductor (CMOS) sensor. A database containing 49,490 digital holograms of individual colonies from 276 clinical strains belonging to 10 of the most prevalent pathogenic bacterial species was used to train the convolutional neural network (CNN). Prediction accuracy was further enhanced by incorporating information across different phylogenetic levels. The performance of the BAIO-DX system was evaluated on 232 strains from the 10 species included in the training data set, as well as 64 strains from 8 species not included in the training data set. For the species included in the training data set, this new method identified 86.6% of the strains at the species level, with a positive-percent agreement of 96.5%. An additional 48% of the strains not identified at the species level could be correctly classified at the genus level through phylogenetic interpretation. These results validate this innovative approach as a candidate for a fully automated, non-destructive, and label-free solution for bacterial identification in clinical microbiology laboratories. IMPORTANCE: Identification of pathogenic bacteria in clinical laboratories is traditionally performed using culture-based methods, such as matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry or biochemical assays. Although recent advances in automation and artificial intelligence (AI) applied to agar plate imaging have reduced manual workload, bacterial identification remains time-consuming and labor-intensive. Here, we present a fully automated, non-destructive, and label-free identification method of bacterial colonies directly on agar plates, combining digital holography and convolutional neural network (CNN) algorithms. After training the system with 276 strains belonging to 10 of the most frequent pathogenic species, the BAIO-DX solution was able to identify 86.6% of new strains at the species level, on a 232-sample test set, achieving a positive-percent agreement of 96.5%. These thorough proof of concept shows that advanced imaging methods with AI-driven analysis can enable reliable, fully automated identification of a substantial proportion of clinically relevant bacteria, offering significant potential to streamline and enhance diagnostic workflows in clinical microbiology.

Indexed as

BacteriaBacteriological TechniquesHolographyAgarAlgorithmsArtificial IntelligenceConvolutional Neural NetworksCulture MediaImage Processing, Computer-AssistedNeural Networks, ComputerPhylogenyAgarCulture Mediaartificial intelligenceautomationbacteriaconvolutional neural networkdigital holographic imagingidentification methodmachine learningmicrobiology

Identifiers

PMID42439565
PMCPMC13436200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.